News
Latest news from CHV and our portfolio companies
Featured News
Acquisition adds next-generation CLAAS® AcuFORM™ Technology to Gore’s portfolio CAUTION: Investigational Device. Limited by federal (or United States) law to investigational use. Outside the United States, the device is intended exclusively for…
Insights & Impacts: The latest from CHV
Novel Foam-Based Design Demonstrates Successful LAAO Seal with No Device-Related Thrombus Conformal Medical, Inc., a
Rejoni announced today that it has closed a $25 million Series B financing. The round
– Clinical and economic benefits of the PreTRM® test and treat strategy illustrated amongst diverse
AtaCor Medical, Inc. has announced completion of its second human clinical study of the Extravascular
Sera Prognostics Inc., The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal health
Seasoned Medical Device Executive, James Reinstein, Appointed as Chief Executive Officer Conformal Medical, Inc., a
– Grant Supports Continued Clinical Development of the Company’s PTM-101 Product and its Potential for
BEDFORD, Mass., – Instylla, Inc., a privately held company developing next-generation liquid embolics for peripheral
Study to support U.S. FDA approval of the novel CLAASâ implant for left atrial appendage
– Patent Validates Novelty and Breadth of Proprietary Sagittari™ Treatment Platform and Expands Potential for